OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 02, 2012
Service providers must focus on delivering a superior customer experience.
Poland's government aims to make the Eastern European country a biotech powerhouse.
May 01, 2012
Readers share their views on bioprocessing challenges, equipment use, and outsourcing trends in our annual bioprocessing equipment and processing survey.
April 02, 2012
Collaboration can begin with a conversation.
Recovery audits and other past practices in procurement can improve the bottom line.
Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.
A Q&A with Erik van den Berg, CEO of AM-Pharma, on recent industry trends.
China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.
March 02, 2012
Brazil's generic-drug market is growing steadily.
The evolving bio/pharmaceutical business model poses risk for CMOs.